Form 4: Boston Scientific Director Receives Equity Awards

Susan E. Morano, a director at Boston Scientific, reports the acquisition of common stock through equity awards.

Summary

• On May 8, 2025, Susan E. Morano, a director of Boston Scientific Corp, acquired 2,081 shares of common stock as an annual equity award.
• These shares vest in full upon the next annual meeting of stockholders.
• The award reflects a value of $215,000 divided by the closing price of common stock on the date of grant.
• Additionally, Morano acquired 605 shares of restricted stock in lieu of 50% of her yearly cash compensation.
• This grant reflects a value of approximately $62,500, representing 50% of the non-employee director compensation program's cash retainer of $125,000, divided by the closing price of the common stock on the date of grant.
• Following these transactions, Morano directly owns 6,639 shares of Boston Scientific common stock.

Sentiment

Score: 7

Explanation: The document reflects standard director compensation practices, indicating stable corporate governance. The director accepting stock in lieu of cash is a positive sign.

Positives

• The equity awards demonstrate Boston Scientific's commitment to aligning director compensation with shareholder interests.
• The acceptance of restricted stock in lieu of cash compensation shows the director's confidence in the company's future performance.

Future Outlook

The shares from the annual equity award will vest upon the next annual meeting of stockholders.

Industry Context

Equity awards are a common practice in corporate governance to incentivize directors and align their interests with those of the shareholders. The specific amounts and vesting schedules can vary based on company size, performance, and industry standards.

Comparison to Industry Standards

• Director compensation packages, including equity awards, vary significantly across the medical device industry.
• Companies like Medtronic and Abbott also utilize equity-based compensation for their directors.
• The value of these awards is typically benchmarked against peer companies to ensure competitiveness and alignment with performance.

Stakeholder Impact

• The equity awards align the director's interests with those of the shareholders, potentially leading to better corporate governance and decision-making.
• The director's confidence in the company, as demonstrated by accepting stock in lieu of cash, can positively influence investor sentiment.

Key Dates

Keywords

Boston Scientific, Director, Equity Award, Common Stock, Restricted Stock, Compensation, Beneficial Ownership, Form 4